Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study
- PMID: 17522151
- PMCID: PMC2095419
- DOI: 10.1136/bjo.2006.113670
Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study
Abstract
Background: The excess risk of bilateral visual impairment (BVI; bilateral visual acuity <0.5) among individuals with amblyopia is an argument for screening for amblyopia, but data are scarce.
Methods: The risk was estimated by determining the incidence of BVI in the Rotterdam Study, a population-based cohort of subjects aged 55 years or over (n = 5220), including 192 individuals with amblyopia (3.7%). Using a multistate lifetable, the lifetime risk and excess period spent with BVI were determined.
Results: The relative risk of BVI for amblyopes was 2.6 (95% confidence interval 1.4-4.5). For individuals with amblyopia, the lifetime risk of BVI was 18%, whereas they lived on average 7.2 years with BVI. For non-amblyopic individuals, these figures were 10% and 6.7 years, respectively.
Conclusion: Amblyopia nearly doubles the lifetime risk of BVI and affected individuals spent an extra six months with BVI. This study provides data for future cost-effectiveness analyses.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment.Br J Ophthalmol. 2007 Nov;91(11):1417-8. doi: 10.1136/bjo.2007.122168. Br J Ophthalmol. 2007. PMID: 17947260 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical